Related posts:

1. CAN-AM ( 11V081000 )
2. Violation of Federal Mattress Flammability Standard Prompts Recall of Ottoman Bed Mattresses by PBteen
3. Photon Climbing Carabiners and Quickdraws Recalled Due to Risk of Injury
4. Petzl America Recalls Belay Devices Due to Fall Hazard
5. OPEN RANGE ( 10V524000 )

Pfizer Announces Voluntary Nationwide Recall of Lo/Ovral®-28
and Norgestrel/Ethinyl Estradiol Tablets Due to
Possibility of Inexact Tablet Counts or Out of Sequence Tablets

Contact:
Consumer:
1-877-509-3935

Media:
Grace Ann Arnold – Media
(845) 602-4768
Graceann.Arnold@Pfizer.com

FOR IMMEDIATE RELEASE – January 31, 2012 – NEW YORK, N.Y. – Pfizer Inc. announced today that it has voluntarily recalled 14 lots of Lo/Ovral®-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic) for customers in the U.S. market. An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence. The cause was identified and corrected immediately.

These products are oral contraceptives indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. These tablets were manufactured and packaged by Pfizer Inc., commercialized by Akrimax Rx Products and labeled under the Akrimax Pharmaceuticals brand. This product is distributed to warehouses, clinics and retail pharmacies nationwide.

As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. These packaging defects do not pose any immediate health risks. However, consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately. Patients who have the affected product (lot numbers are provided below) should notify their physician and return the product to the pharmacy.

These products are packaged in blister packs containing 21 tablets of active ingredients and seven tablets of inert ingredients. Correct dosing of this product is important in avoiding the associated risks of an unplanned pregnancy. Correctly packaged blister packs are pictured here.

Any adverse events that may be related to the use of these products should be reported to Akrimax Medical Information at 1-877-509-3935 (8 AM to 7 PM Mon-Fri CST) or to FDA’s Med Watch Program either online, by regular mail or by fax.

Online:              www.fda.gov/medwatch/report.htm
Regular Mail:   Use postage-paid, pre-addressed Form FDA 3500
available at: www.fda.gov/MedWatch/getforms.htm. Mail
to the address on the pre-addressed form.
Fax:                   1-800-FDA-0178

Pfizer has responded rapidly to ensure that its products continue to meet the company’s high quality standards. The safety of patients who take our medicines is our first priority.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Lot numbers of affected packs of Lo/Ovral®-28 (norgestrel and ethinyl estradiol)Tablets and Norgestrel and Ethinyl Estradiol Tablets (generic) follow on the table below:

Related posts:

1. Caraco Digoxin Tablets Recalled
2. McNeil Consumer Healthcare Over-The-Counter Products: Recall
3. International Vitamin Corporation Recalls Live Better Vitamins Due to Failure to Meet Child-Resistant Closure Requirement
4. International Vitamin Corporation Recalls Live Better Vitamins Due to Failure to Meet Child-Resistant Closure Requirement

Related posts:

1. Mylotarg (gemtuzumab ozogamicin): Market Withdrawal
2. Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients
3. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
4. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
5. Mesothelioma Patients’ Lives Extended Years In Study

Related posts:

1. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
2. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
3. CooperVision Avaira Toric Soft Contact Lenses: Class 1 Recall- Unintended Residue on Lenses
4. Delivering Cisplatin By Inhaler For Treating Lung Cancer
5. Delivering Cisplatin By Inhaler For Treating Lung Cancer

Related posts:

1. Magic Power Coffee: Undeclared Drug Ingredient
2. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
3. MasXtreme Capsules (Natural Wellness) – product contains undeclared drug ingredient
4. Birth Defects Caused by Dangerous Drugs are avoidable
5. FDA Takes Legal Action Against Dietary Supplement Maker In Pennsylvania

Related posts:

1. Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication
2. Sprycel (dasatinib): Drug Safety Communication – Risk of Pulmonary Arterial Hypertension
3. Mesothelioma Patients’ Lives Extended Years In Study
4. Cardiac Science Automated External Defibrillators – Powerheart, Cardiovive, NK, Responder models: Class I Recall
5. Propylthiouracil

Related posts:

1. GLAVAL ( 11V402000 )
2. Undercover Inspections of Funeral Homes in Nine States and Washington, D.C. Press Funeral Homes to Comply with Consumer Protection Law
3. Emergency Exit Signs Recalled by Best Lighting Products Due to Failure to Illuminate
4. Emergency Exit Signs Recalled by Best Lighting Products Due to Failure to Illuminate
5. Benicar (olmesartan): Ongoing Safety Review

Related posts:

1. Recall to Repair: Whitco Company LP Stadium Light Poles Can Fall Over, Posing Risk of Serious Injury and Death
2. Photon Climbing Carabiners and Quickdraws Recalled Due to Risk of Injury
3. Medical Malpractice Lawsuits
4. BD Q-Syte Luer Access Devices: Recall
5. BD Q-Syte Luer Access Devices: Recall

Related posts:

1. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
2. GnRH Agonists: Safety Review of Drug Class Used to Treat Prostate Cancer
3. Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety
4. Oral Bisphosphonates: Ongoing Safety Review of Atypical Subtrochanteric Femur Fractures
5. Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication

Related posts:

1. McNeil Consumer Healthcare Over-the-Counter Infants’ and Children’s Products: Recall
2. CPSC Educates New Parents on Safe Babywearing
3. MasXtreme Capsules (Natural Wellness) – product contains undeclared drug ingredient
4. FDA Takes Legal Action Against Dietary Supplement Maker In Pennsylvania
5. Infant Deaths Prompt CPSC Warning About Sling Carriers for Babies

Related posts:

1. Cleviprex (clevidipine butyrate): Recall
2. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
3. Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall – Possibility of Inexact Tablet Counts or Out of Sequence Tablets
4. Cardiac Science Automated External Defibrillators (Powerheart, Cardiovive, CardioLife, NK, Responder models): Class I Recall
5. McNeil Consumer Healthcare Over-the-Counter Infants’ and Children’s Products: Recall

Related posts:

1. Virility Max: Recall – Undeclared Drug Ingredient
2. MasXtreme Capsules (Natural Wellness) – product contains undeclared drug ingredient
3. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
4. FDA Takes Legal Action Against Dietary Supplement Maker In Pennsylvania
5. Employment Lawsuits

Related posts:

1. Xigris [drotrecogin alfa (activated)]: Market Withdrawal – Failure to Show Survival Benefit
2. Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication
3. Senate Report Questions Avandia
4. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
5. Arkansas woman files Reglan lawsuit

Related posts:

1. FTC Seeks Public Input in Review of Textile Labeling Rules
2. Teleflex Arrow IV Tubing Sets, Accessories, and Embolectomy Catheters: Recall
3. Judge says Vytorin Forum postings can stay
4. Communication Failures Put Diagnostic Physicians At Increased Risk For Medical Malpractice Claims
5. CPSC Issues Warning on Children’s Winter and Holiday-Themed Charm Bracelets with High Levels of Cadmium

Related posts:

1. Intravenous Medications Manufactured by Claris: Recall due to contamination of products
2. Hylenex recombinant (hyaluronidase human injection): Recall
3. Cleviprex (clevidipine butyrate): Recall
4. PediaCare Children’s Products [Blacksmith Brand]: Recall of four products
5. LBCE ( 11V348000 )

Related posts:

1. Propylthiouracil
2. Arctic Cat Recalls Snowmobiles Due to a Loss of Control Hazard
3. Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements
4. Obama To Release Revised Health Reform Proposal On Wednesday
5. Price Benowitz LLP Announces its New Virginia Personal Injury Website

Related posts:

1. Cleviprex (clevidipine butyrate): Recall
2. GammaGard Liquid, Immune Globulin Intravenous (Human)
3. Hospira Brand Liposyn and Propofol: Recall
4. CooperVision "Avaira" Contact Lens Recall Problems Continue
5. McNeil Consumer Healthcare Over-The-Counter Products: Recall

Related posts:

1. EPA Reminds Public: Avoid Contact with Contaminated Flood Water – Flood water can contain raw sewage, other harmful contaminants  (CT, ME, MA, NH, RI, VT)
2. U.S. EPA Takes Action Against South San Francisco Meat Processing Facility Following Hazardous Chemical Air Releases (CA)
3. Women’s Multivitamins Recalled by GNC Due to Failure to Meet Child-Resistant Closure Requirements
4. Women’s Multivitamins Recalled by GNC Due to Failure to Meet Child-Resistant Closure Requirements
5. CPSC Chairman To Honor Consumer Product Safety Leaders

Related posts:

1. Metronidazole injection 500 mg / 100 ml: Voluntary recall due to non-sterility
2. Hospira Brand Liposyn and Propofol: Recall
3. Delivering Cisplatin By Inhaler For Treating Lung Cancer
4. Delivering Cisplatin By Inhaler For Treating Lung Cancer
5. VOLVO ( 10V564000 )

Related posts:

1. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
2. Cardiac Science Automated External Defibrillators – Powerheart, Cardiovive, NK, Responder models: Class I Recall
3. DEGS of Narrows LLC Settles Clean Air Act Violations (VA)
4. Zicam linked to Loss of Sense of Smell
5. Essex Junction, Vermont Wastewater Treatment Plant Recognized for Excellence (VT)

Related posts:

1. Hylenex recombinant (hyaluronidase human injection): Recall
2. Cleviprex (clevidipine butyrate): Recall
3. WinRho SDF (Rho(D) Immune Globulin Intravenous (Human): Risk of Intravascular Hemolysis
4. Trilipix (fenofibric acid): Drug Safety Communication – Label Change
5. Baxter HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems: Class I Recall

Related posts:

1. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
2. Benicar (olmesartan): Ongoing Safety Review
3. Delivering Cisplatin By Inhaler For Treating Lung Cancer
4. Delivering Cisplatin By Inhaler For Treating Lung Cancer
5. Senate Report Questions Avandia

Related posts:

1. Nine Manufacturers, Distributors Announce Consumer Recall of Pourable Gel Fuel Due to Burn and Flash Fire Hazards
2. Napa Home & Garden Recalls NAPAfire and FIREGEL Pourable Gel Fuel Due to Fire and Burn Hazards
3. Pacific Décor Recalls Pourable Gel Fuel Due to Burn and Flash Fire Hazards
4. Bird Brain Recalls Pourable Gel Fuel Due to Burn and Flash Fire Hazards
5. Evergreen Enterprises Recalls Pourable Gel Fuel Due to Burn and Flash Fire Hazards

Related posts:

1. Intravenous Medications Manufactured by Claris: Recall due to contamination of products
2. Teleflex Arrow IV Tubing Sets, Accessories, and Embolectomy Catheters: Recall
3. Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients
4. Mizuho OSI Modular Table Systems: Class I Recall – Reports of Patient Injury
5. Covidien Initiates Voluntary Recall of Certain Shiley™ Tracheostomy Tubes

Related posts:

1. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
2. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
3. Xigris [drotrecogin alfa (activated)]: Market Withdrawal – Failure to Show Survival Benefit
4. Propylthiouracil
5. Arctic Cat Recalls Snowmobiles Due to a Loss of Control Hazard

Related posts:

1. Target Recalls Children’s Belts Due to Violation of Lead Paint Standard
2. Children’s Bracelets Recalled by Chandigarh Fashion Due to Violation of Lead Paint Standard
3. Sportime Recalls Sports Balls Due to Violation of Lead Paint Standard
4. Youth Tiara Recalled by Wilton Industries Due to Lead Exposure Hazard
5. Children’s Educational Kits Recalled by Carolina Biology Supply Due to Risk of Lead Exposure

Related posts:

1. Benicar (olmesartan): Ongoing Safety Review
2. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
3. Proton Pump Inhibitors (PPI): Class Labeling Change
4. Rare Diseases Pose Medico-legal Risk, From Medical And Dental Defence Union Of Scotland
5. Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety

Related posts:

1. CPSC Adopts Independent Third Party Testing and Certification Rules for Children’s Products
2. Children’s Sleepwear Recalled by Sage Creek Organics Due to Violation of Federal Flammability Standard
3. Children’s Sleepwear Recalled by Sage Creek Organics Due to Violation of Federal Flammability Standard
4. Fashionviews Inc. Recalls P.Jamas Children’s Sleepwear Due to Violation of Federal Flammability Standard
5. CPSC Announces New, Lower Limit for Lead Content in Children’s Products

Related posts:

1. Cardiac Science Automated External Defibrillators (Powerheart, Cardiovive, CardioLife, NK, Responder models): Class I Recall
2. Cleviprex (clevidipine butyrate): Recall
3. Virility Max: Recall – Undeclared Drug Ingredient
4. McNeil Consumer Healthcare Over-The-Counter Products: Recall
5. Cardiac Science Automated External Defibrillators – Powerheart, Cardiovive, NK, Responder models: Class I Recall

Related posts:

1. Orlistat (marketed as Alli and Xenical): Labeling Change
2. Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug
3. Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients
4. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
5. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment